Apocrine Sweat Glands: Development, Structure, and Clinical Significance

The apocrine sweat gland occupies a curious position in human biology. Unlike its eccrine counterpart—essential for thermoregulation and distributed across nearly all body surfaces—the apocrine gland is confined to a few anatomically discrete regions, becomes functional only at puberty, and serves no clearly defined physiological purpose in modern humans.

Medical school foundation reminder: In histology, you learned that secretory glands classify as merocrine (eccrine), apocrine (partial cell loss), or holocrine (complete cell destruction like sebaceous glands). However, human "apocrine" glands are actually merocrine by modern criteria—the name persists from early misinterpretation of decapitation secretion. The true significance lies in their androgen dependence, pilosebaceous association, and scent gland evolutionary origin.

These glands are evolutionary remnants of the scent-marking systems found in other mammals, where pheromone-laden secretions communicate reproductive status, territorial boundaries, and individual identity. In humans, apocrine secretions are primarily of clinical interest for their role in body odor and in diseases such as hidradenitis suppurativa and Fox–Fordyce disease.

Clinical significance: Understanding apocrine biology is essential for managing hidradenitis suppurativa, axillary hyperhidrosis with odor, and Fox-Fordyce disease. These glands also serve as a model for androgen-sensitive adnexal structures in dermatology.

Histological appearance: Apocrine glands appear as large, dilated secretory coils with eosinophilic cytoplasm and decapitation secretion artifacts (historically misinterpreted as true apocrine secretion).

Dermoscopic correlation: Apocrine regions show enlarged follicular openings, coarse hair emergence, and in hidradenitis suppurativa, black dots (comedone-like plugging) and yellow structureless areas (suppuration).

Evolutionary Context

In most mammals, apocrine glands are far more abundant and physiologically important than in humans. Dogs, for example, possess apocrine glands across their entire body surface, while the anal glands of skunks and the preorbital glands of deer represent highly specialized apocrine derivatives. These glands produce complex mixtures of volatile organic compounds that, when modified by skin bacteria, generate species-specific and individual-specific odors crucial for social communication.

Humans have largely lost the olfactory acuity and behavioral responses that would make apocrine signaling meaningful. Nevertheless, emerging research suggests that human apocrine secretions may still convey chemical information that influences mood, sexual attraction, and even menstrual synchrony—though these findings remain controversial. From a dermatological perspective, the significance of the apocrine gland lies primarily in its pathology rather than its physiology.

Anatomical Distribution

Apocrine sweat glands are found only in specific body regions:

The axillae contain the highest concentration of apocrine glands in the human body. These glands are responsible for the characteristic axillary odor that develops after puberty—a phenomenon absent in prepubertal children, whose axillary sweat derives entirely from eccrine glands.

The anogenital region harbors apocrine glands in the labia majora, perineum, and perianal skin. In this location, apocrine secretions contribute to the distinctive odor of the genitalia and may have ancestral significance in reproductive signaling.

The periumbilical area and areolae/nipples contain smaller populations of apocrine glands. The areolar glands (Montgomery glands) are actually pilosebaceous units, but true apocrine glands are interspersed among them.

Modified apocrine glands exist in specialized locations: the ceruminous glands of the external auditory canal produce the lipid-rich secretion that combines with desquamated keratinocytes to form cerumen (earwax), while the glands of Moll in the eyelid margins protect the conjunctival surface and contribute to the tear film.

Embryological Development

Apocrine glands develop in close association with the pilosebaceous follicle, arising from the upper follicular epithelium during the fourth to fifth month of gestation. Unlike eccrine glands—which differentiate directly from the surface ectoderm—apocrine glands descend from the same epithelial invagination that gives rise to the hair follicle and sebaceous gland. This shared developmental origin explains why the apocrine duct opens into the follicular infundibulum rather than directly onto the epidermal surface.

Despite being morphologically complete at birth, apocrine glands remain functionally quiescent throughout childhood. Activation occurs only at puberty in response to rising levels of androgens—primarily testosterone and its metabolite dihydrotestosterone (DHT). This androgen dependence parallels the pubertal activation of terminal hair growth and sebaceous gland hyperfunction, all of which reflect the coordinated maturation of the pilosebaceous unit.

The contrast with eccrine gland development is striking. Eccrine glands are fully functional from birth, require no hormonal activation, and operate independently of the pilosebaceous apparatus. This distinction has clinical implications: conditions affecting the pilosebaceous unit (such as acne or hidradenitis suppurativa) frequently involve apocrine glands, while purely eccrine disorders (such as hyperhidrosis or miliaria) spare them entirely.

Anatomy of the Apocrine Gland

Secretory Portion

The apocrine gland consists of a large, coiled secretory portion located deep in the dermis or subcutaneous fat, connected by a short, straight duct to the upper hair follicle. The secretory coil is substantially larger than that of the eccrine gland and possesses a wide lumen—often visible histologically as a dilated, fluid-filled space.

The secretory epithelium consists of a single layer of columnar cells whose height varies with secretory activity. In the resting state, the cells are tall with abundant apical cytoplasm; following secretion, they may appear cuboidal or flattened. These secretory cells are surrounded by a well-developed layer of myoepithelial cells that contract to expel glandular contents into the duct.

Histologically, the apocrine secretory epithelium is distinguished from eccrine epithelium by several features: the larger cell size, the wider lumen, the absence of distinct clear and dark cell populations, and the characteristic decapitation secretion (apocrine secretion) in which the apical cytoplasm pinches off into the lumen. This mechanism, while lending the glands their name (from Greek apo-, "away from"), is now understood to be a fixation artifact in most instances—true secretion is predominantly merocrine or holocrine depending on circumstances.

Apocrine Duct

The apocrine duct is shorter and wider than the eccrine duct. It consists of a double layer of cuboidal cells supported by myoepithelial cells and drains into the follicular infundibulum above the entry point of the sebaceous duct. This anatomical arrangement means that apocrine secretions mix with sebum before reaching the skin surface.

The apocrine acrosyringium—the intraepidermal portion of the duct—is therefore absent as a distinct structure; instead, apocrine secretions exit through the follicular ostium alongside sebum and desquamated keratinocytes. This shared exit pathway has implications for the pathophysiology of follicular occlusive diseases.

Innervation and Regulation

The mechanism of apocrine gland stimulation remains incompletely understood. Unlike eccrine glands, which are densely innervated by cholinergic sympathetic fibers, apocrine glands receive sparse or no direct nerve supply. Studies of human axillary skin have failed to demonstrate nerve fibers in close proximity to apocrine secretory coils, suggesting that regulation occurs through circulating humoral factors rather than direct neural control.

Apocrine glands express β-adrenergic receptors (predominantly β₂ and β₃ subtypes) and purinergic receptors, and secretion can be induced by systemic administration of catecholamines such as epinephrine. This explains the increase in body odor associated with emotional stress and fear—states characterized by elevated circulating catecholamines. Cholinergic stimulation, by contrast, has minimal effect on apocrine secretion.

The absence of direct innervation distinguishes the apocrine from the eccrine gland and has therapeutic implications. Botulinum toxin, which blocks acetylcholine release at the neuroglandular junction, is highly effective for eccrine hyperhidrosis but theoretically less applicable to disorders of apocrine sweating. In practice, however, axillary botulinum toxin injections reduce both eccrine and apocrine contributions to body odor, likely by reducing the moisture necessary for bacterial metabolism.

Secretion and Composition

Apocrine secretion is continuous at a low basal rate, with periodic surges in response to adrenergic stimulation. The primary secretion is a milky, viscous, slightly alkaline fluid containing proteins, lipids, steroids, and ammonium compounds. Fresh apocrine sweat is sterile and odorless; the characteristic axillary odor develops only after bacterial modification of secreted precursors.

The key odoriferous compounds in axillary apocrine secretion include:

3-methyl-2-hexenoic acid (3M2H): The dominant component of "human body odor," this branched-chain fatty acid is produced when Corynebacterium species cleave odorless precursor molecules secreted by apocrine glands. The precursors are glutamine conjugates of 3M2H that are released intact and activated by bacterial aminoacylases.

3-hydroxy-3-methylhexanoic acid (HMHA): A related compound that contributes to the acidic, "sweaty" component of axillary odor.

5α-androstenol and 5α-androstenone: Steroid derivatives that produce musky, urinous odors. These compounds are of interest for their potential role in human chemical communication, though evidence for pheromone-like activity remains equivocal.

The composition of apocrine secretion varies with sex, menstrual cycle phase, diet, and genetic factors. Notably, the ABCC11 gene encodes a membrane transporter expressed in apocrine glands; a common polymorphism (rs17822931) results in "dry" earwax and markedly reduced axillary odor—a trait prevalent in East Asian populations. This finding provides molecular evidence that apocrine gland function is under genetic control.

Clinical Correlations: Apocrine Gland Disorders

Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic, inflammatory, scarring disease of the apocrine gland-bearing areas—primarily the axillae, groin, perianal region, and inframammary folds. The condition typically begins after puberty and is characterized by recurrent painful nodules, abscesses, sinus tracts, and progressive scarring.

For decades, hidradenitis was conceptualized as primarily an apocrine gland disorder—hence its alternative name, "apocrine acne." However, current understanding emphasizes follicular occlusion as the initiating event, with the apocrine gland playing a secondary role. Keratin plugging of the terminal hair follicle leads to rupture of the follicular epithelium, release of keratinous debris into the dermis, and an intense inflammatory response. Apocrine glands may become secondarily involved as inflammation spreads through the interconnected pilosebaceous/apocrine apparatus.

The pathogenesis of HS involves genetic susceptibility (mutations in γ-secretase complex genes including NCSTN, PSEN1, and PSENEN), immune dysregulation (IL-17 and TNF-α predominant inflammation), bacterial colonization (particularly anaerobes and biofilm-forming organisms), and lifestyle factors (obesity, smoking). Treatment approaches include antibiotics, anti-inflammatory agents (TNF-α inhibitors, IL-17 inhibitors), hormonal therapy, and surgical excision of affected tissue.

Fox–Fordyce Disease

Fox–Fordyce disease (apocrine miliaria) is an uncommon condition characterized by intensely pruritic, skin-colored papules localized to apocrine gland-bearing areas, particularly the axillae. The disease predominantly affects women of reproductive age and often improves during pregnancy and after menopause.

Histologically, Fox–Fordyce disease shows occlusion of the apocrine duct by a keratinous plug, with perifollicular inflammation and rupture of the duct. The mechanism is analogous to eccrine miliaria but involves the apocrine acrosyringium within the follicular infundibulum. Why certain individuals develop this ductal obstruction remains unclear, though hormonal factors are strongly implicated by the female predominance and improvement with hormonal fluctuations.

Treatment of Fox–Fordyce disease is challenging. Topical and intralesional corticosteroids provide temporary relief. Oral contraceptives, clindamycin, and isotretinoin have been tried with variable success. Recently, botulinum toxin injections have shown efficacy, presumably by reducing the volume of secretion that predisposes to ductal retention.

Apocrine Chromhidrosis

Apocrine chromhidrosis is a rare condition in which apocrine sweat is visibly colored—typically yellow, green, blue, or black. The pigment responsible is lipofuscin, a lipid-containing pigment that accumulates in apocrine secretory cells and is released into the sweat. The condition most commonly affects the face and axillae.

True apocrine chromhidrosis must be distinguished from pseudochromhidrosis, in which colorless sweat becomes pigmented after secretion due to interaction with surface bacteria (especially chromogenic Corynebacterium species), fungi, or exogenous dyes. The distinction is made by expressing sweat directly from the glandular orifice and observing its native color.

Treatment of apocrine chromhidrosis includes topical capsaicin (which depletes secretory granules), botulinum toxin (which reduces secretion), and manual expression of accumulated pigment.

Apocrine Gland Tumors

Tumors of apocrine differentiation are rare but clinically important. Apocrine hidrocystoma is a benign, dome-shaped cyst containing bluish fluid, typically occurring on the periorbital skin. Syringocystadenoma papilliferum is a benign papillomatous growth, often presenting on the scalp in association with a nevus sebaceous. Apocrine carcinoma is a rare malignancy that may arise de novo or from pre-existing benign lesions; it requires wide excision and carries a variable prognosis.

Modified Apocrine Glands

Ceruminous Glands

The ceruminous glands of the external auditory canal are modified apocrine glands that produce the lipid and protein components of cerumen. Cerumen—a mixture of glandular secretion, sebum, and desquamated keratinocytes—protects the tympanic membrane and ear canal from desiccation, infection, and foreign body intrusion.

Two cerumen phenotypes exist: "wet" (sticky, brownish) and "dry" (flaky, gray). These phenotypes are determined by the same ABCC11 polymorphism that affects axillary odor, with the dry earwax allele predominating in East Asian populations. Cerumen impaction is a common clinical problem, and excessive cerumen production or inadequate self-cleaning can lead to conductive hearing loss.

Glands of Moll

The glands of Moll are small apocrine glands located along the eyelid margins, opening near the bases of the eyelashes. Their secretion contributes to the lipid layer of the tear film and helps maintain the hydration of the ocular surface.

Hordeolum externum (external stye) represents acute infection of a gland of Moll or a Zeis sebaceous gland, manifesting as a painful, erythematous nodule at the lid margin. Treatment includes warm compresses and, if necessary, incision and drainage.

Apocrine hidrocystoma of the eyelid (cyst of Moll) is a benign, translucent, slow-growing cyst arising from the glands of Moll. Multiple lesions may occur in some patients. Excision or puncture with cautery of the cyst lining is curative.

Summary

Apocrine sweat glands are androgen-dependent structures that develop in association with the pilosebaceous unit and become functional only at puberty. They are confined to the axillae, anogenital region, periumbilical area, and nipples, with modified forms in the ear canal (ceruminous glands) and eyelids (glands of Moll). Unlike eccrine glands, apocrine glands lack direct cholinergic innervation and are instead stimulated by circulating catecholamines via β-adrenergic receptors. Their secretion is initially sterile and odorless; bacterial metabolism of apocrine precursors produces the characteristic compounds responsible for body odor. Clinically important disorders include hidradenitis suppurativa (a chronic inflammatory follicular disease), Fox–Fordyce disease (apocrine miliaria), and apocrine chromhidrosis. The ABCC11 gene polymorphism influences both apocrine secretion and earwax type, demonstrating the genetic control of apocrine function.

This section provides the framework for understanding apocrine gland pathology, particularly hidradenitis suppurativa, which is discussed in detail in later clinical chapters.